CaniLeish

RSS

Withdrawn

This medicine's authorisation has been withdrawn

Leishmania infantum excreted secreted proteins
MedicineVeterinaryWithdrawn
  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn.

български (BG) (279.52 KB - PDF)

View

español (ES) (117.04 KB - PDF)

View

čeština (CS) (143.38 KB - PDF)

View

dansk (DA) (98.61 KB - PDF)

View

Deutsch (DE) (163.28 KB - PDF)

View

eesti (ET) (160.37 KB - PDF)

View

ελληνικά (EL) (304.63 KB - PDF)

View

français (FR) (163.73 KB - PDF)

View

italiano (IT) (102.6 KB - PDF)

View

latviešu (LV) (220.7 KB - PDF)

View

lietuvių (LT) (203.83 KB - PDF)

View

magyar (HU) (126.09 KB - PDF)

View

Malti (MT) (157.76 KB - PDF)

View

Nederlands (NL) (99.79 KB - PDF)

View

polski (PL) (147 KB - PDF)

View

português (PT) (97.25 KB - PDF)

View

română (RO) (158.19 KB - PDF)

View

slovenčina (SK) (195.36 KB - PDF)

View

slovenščina (SL) (125.11 KB - PDF)

View

suomi (FI) (163.9 KB - PDF)

View

svenska (SV) (96.48 KB - PDF)

View

Product information

български (BG) (806.53 KB - PDF)

View

español (ES) (690.86 KB - PDF)

View

čeština (CS) (874.83 KB - PDF)

View

dansk (DA) (814.05 KB - PDF)

View

Deutsch (DE) (718.44 KB - PDF)

View

eesti (ET) (764.47 KB - PDF)

View

ελληνικά (EL) (952.17 KB - PDF)

View

français (FR) (763.41 KB - PDF)

View

hrvatski (HR) (750.72 KB - PDF)

View

italiano (IT) (688.64 KB - PDF)

View

latviešu (LV) (1001.02 KB - PDF)

View

lietuvių (LT) (878.17 KB - PDF)

View

magyar (HU) (790.22 KB - PDF)

View

Malti (MT) (966.19 KB - PDF)

View

Nederlands (NL) (792.81 KB - PDF)

View

polski (PL) (765.13 KB - PDF)

View

português (PT) (784.26 KB - PDF)

View

română (RO) (760.68 KB - PDF)

View

slovenčina (SK) (1.02 MB - PDF)

View

slovenščina (SL) (852.11 KB - PDF)

View

suomi (FI) (738.32 KB - PDF)

View

svenska (SV) (705.65 KB - PDF)

View

Íslenska (IS) (683.5 KB - PDF)

View

norsk (NO) (887.59 KB - PDF)

View

български (BG) (122.86 KB - PDF)

View

español (ES) (56.46 KB - PDF)

View

čeština (CS) (105.51 KB - PDF)

View

dansk (DA) (55.54 KB - PDF)

View

Deutsch (DE) (65.09 KB - PDF)

View

eesti (ET) (57.9 KB - PDF)

View

ελληνικά (EL) (124.83 KB - PDF)

View

français (FR) (55.93 KB - PDF)

View

italiano (IT) (58.32 KB - PDF)

View

latviešu (LV) (106.77 KB - PDF)

View

lietuvių (LT) (101.46 KB - PDF)

View

magyar (HU) (96.57 KB - PDF)

View

Malti (MT) (103.95 KB - PDF)

View

Nederlands (NL) (55.85 KB - PDF)

View

polski (PL) (98.5 KB - PDF)

View

português (PT) (59.32 KB - PDF)

View

română (RO) (96.81 KB - PDF)

View

slovenčina (SK) (105.93 KB - PDF)

View

slovenščina (SL) (87.46 KB - PDF)

View

suomi (FI) (58.6 KB - PDF)

View

svenska (SV) (56.33 KB - PDF)

View

Íslenska (IS) (57.08 KB - PDF)

View

norsk (NO) (52 KB - PDF)

View

Product details

Name of medicine
CaniLeish
Active substance
Leishmania infantum excreted secreted proteins
International non-proprietary name (INN) or common name
Leishmania infantum excreted secreted proteins
Anatomical therapeutic chemical veterinary (ATCvet) code
QI07AO

Pharmacotherapeutic group

Immunologicals

Authorisation details

EMA product number
EMEA/V/C/002232

Assessment history

This page was last updated on

Share this page